TransMedics Group Inc (TMDX) - Total Liabilities
Based on the latest financial reports, TransMedics Group Inc (TMDX) has total liabilities worth $940.81 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore TMDX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
TransMedics Group Inc - Total Liabilities Trend (2006–2025)
This chart illustrates how TransMedics Group Inc's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of TransMedics Group Inc to measure how efficiently the company converts operating cash flow to free cash.
TransMedics Group Inc Competitors by Total Liabilities
The table below lists competitors of TransMedics Group Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Atkore International Group Inc
NYSE:ATKR
|
USA | $1.57 Billion |
|
Poco Holding Co Ltd
SHE:300811
|
China | CN¥881.42 Million |
|
Meitu Inc
F:M5U
|
Germany | €3.65 Billion |
|
Enliven Therapeutics Inc.
NASDAQ:ELVN
|
USA | $11.49 Million |
|
Jiangzhong Pharmaceutical Co Ltd
SHG:600750
|
China | CN¥2.14 Billion |
|
Ultragenyx
NASDAQ:RARE
|
USA | $1.52 Billion |
|
Blackstone Mortgage Trust Inc
NYSE:BXMT
|
USA | $16.21 Billion |
|
Nantong Haixing Electronics Co Ltd
SHG:603115
|
China | CN¥950.01 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down TransMedics Group Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TMDX market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.90 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how TransMedics Group Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for TransMedics Group Inc (2006–2025)
The table below shows the annual total liabilities of TransMedics Group Inc from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $595.27 Million | +3.44% |
| 2024-12-31 | $575.47 Million | +1.17% |
| 2023-12-31 | $568.85 Million | +533.66% |
| 2022-12-31 | $89.77 Million | +33.91% |
| 2021-12-31 | $67.04 Million | +39.27% |
| 2020-12-31 | $48.13 Million | -4.97% |
| 2019-12-31 | $50.65 Million | +7.81% |
| 2018-12-31 | $46.98 Million | -77.16% |
| 2017-12-31 | $205.72 Million | +965.10% |
| 2016-12-31 | $19.32 Million | +216.69% |
| 2006-12-31 | $6.10 Million | -- |
About TransMedics Group Inc
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic con… Read more